Natasha completed her PhD from Monash University in 2022 in the Australian Centre for Blood Diseases. Her research involved characterising the therapeutic potential of targeted CD39 in several preclinical stroke models. She previously obtained her Bachelor of Science (Hons) from the University of Melbourne in 2015 with first class honours.

After her PhD, she joined Monash Biomedical Imaging, and was trained in several imaging modalities such as MRI and magnetic particle imaging. She also has extensive experience in animal procedures and surgery. Current research interests include using various imaging modalities to characterise and compare therapies in preclinical stroke models.